2017 Russian clinical practice guidelines for differentiated thyroid cancer diagnosis and treatment

Эндокринная хирургия

Roman A. Chernikov¹  Nikolay S. Kuznetsov¹  Vladimir E. Vanushko²  Ali M. Mudunov²  Dmitriy G. Beltsevich²  Pavel O. Rumiantsev²  Galina A. Melnichenko²  Vladimir G. Polyakov²  Aleksandr Yu. Abrosimov³  Ilja V. Sleptsov⁴  Ilja S. Romanov⁴  Sergey O. Podvyaznikov⁴  Valentin V. Fadeyev⁵  Andrey P. Polyakov⁶  Sergey L. Vorobyov⁷ 

[1]  Endocrinology Research Centre;I.M. Sechenov First Moscow State Medical University;N.N. Blokhin Russian Cancer Research Center;National Medical Research Radiological Centre;Russian Medical Academy of Continuous Professional Education;The Russian National Research Medical University named after N.I. Pirogov;

关键词: differentiated thyroid cancer;    fine-needle aspiration;    fnab;    fna;    screening;    calcitonin;    cytology;    suppressive therapy;    thyroid replacement therapy;    targeted therapy;    radioactive iodine-refractory differentiated thyroid cancer;   

DOI  :  10.14341/serg201716-27

来源: DOAJ

【 摘 要 】

The Russian clinical practice guidelines for diagnosis and treatment of differentiated thyroid cancer is dedicated to the management of patients with differentiated thyroid cancer. The guideline modifications 2016 include the following matters: indication for fine-needle aspiration biopsy, calcitonin screening, standards for biopsy results, new positions of postoperative risk stratification, indication for suppressive therapy and thyroid replacement therapy, targeted therapy in patients with radioiodine-refractory differentiated thyroid cancer.

【 授权许可】

Unknown